Increased synthesis of specific eicosanoids in rejected corneal grafts

References

• Pleyer U., Steuhl K. P, Weidle E. G, Lisch W., Thiel H. J. Corneal graft rejection: incidence, manifestation and interaction of clinical subtypes. Transplantation 1992; 24: 2034–2037
   Web of Science ®Google Scholar
• Ramos E., Closa D., Hotter G., Rosello-Catafau J., Gelpi E., Fernandez-Cruz L. The impact of arterialization on prostanoid generation after liver transplantation in the rat. Transplantation 1994; 58: 140–144
   PubMed Web of Science ®Google Scholar
• Nassiri M., Viciana A., Padmanabhan J., Streilein J. W., Ruiz P. Lymphoid organ production of immu-nomodulatory eicosanoids in mice resistant to neonatal tolerance induction. Transplantation 1994; 57: 1643–1652
   PubMed Web of Science ®Google Scholar
• Pi F., Hotter G., Closa D., Rosello-Catafau J., Bulbena O., Badosa F., Morris M., Fernandez-Cruz L., Gelpi E. Effect of a platelet-activating factor antagonist and desferrioxamine administration on eicosanoid production in rat pancreas transplantation. Transplantation 1994; 57: 12–17
   PubMed Web of Science ®Google Scholar
• Iyobe T., Izumi R., Shimizu K. The immuno-suppressive effect of 5-lipoxygenase inhibitor on liver allotransplantation in rats. Transplantation 1994; 56: 518–523
   Web of Science ®Google Scholar
• Fan P. Y, Albrightson C. R, Howell D. N, Best C, Badger A. M., Coffman T. M. The azaspirane SKF 105685 ameliorates renal allograft rejection in rats. J. Am. Soc: Nephrol. 1993; 3: 1680–1685
   PubMed Web of Science ®Google Scholar
• Bazan H. E. P., Birkle D. L, Beuerman R., Bazan N. G. Cryogenic lesion alters the metabolism of arachidonic acid in rabbit cornea layers. Invest. Ophthal-mol. Vis. Sci. 1985; 26: 474–480
   PubMed Web of Science ®Google Scholar
• Bazan H. E. P., Birkle D. L, Beuerman R., Bazan N. G. Inflammation-induced stimulation of the synthesis of prostaglandins and lipoxygenase-reaction products in rabbit cornea. Curr. Eye Res. 1985; 4: 175–179
   PubMed Web of Science ®Google Scholar
• Bazan H. E. P. Corneal injury alters eicosanoid formation in the rabbit anterior segment. in vivo. Invest. Ophthalmol. Vis. Sci. 1987; 28: 314–319
   PubMed Web of Science ®Google Scholar
• Hurst J. S, Balazy M., Bazan H. E. P., Bazan N. G. The epithelium, endothelium, and stroma of the rabbit cornea generate 12(S)-hydroxyeicosatetraenoic acid as the main lipoxygenase metabolite in response to injury. J. Biol. Chem. 1991; 266: 6726–6730
   PubMed Web of Science ®Google Scholar
• Wiggins R. E, Jafri M. S., Praia A. D. 12(S) Hydroxy-5,8,10,14-eicosatetraenoic acid is a more potent neutrophil chemoattractant than the 12(R) epimer in the rat cornea. Prostaglandins 1990; 40: 131–141
   PubMedGoogle Scholar
• Neufeld A. H, Jumblatt M. M, Martkin E. D., Raymond G. M. Maintenance of corneal endothelial cell shape by prostaglandin E2: effect of EGF and indomethacin. Invest. Ophthalmol. Vis. Sci. 1986; 27: 1437–1442
   PubMed Web of Science ®Google Scholar
• Deutsch T. A., Hughes W. F. Suppressive effects of indomethacin on thermally induced neovascular-ization of rabbit corneas. Am. J. Ophthalmol. 1979; 87: 536–540
   PubMed Web of Science ®Google Scholar
• Haynes W. L, Proia A. D., Klintworth G. K. Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat. Invest. Ophthalmol. Vis. Sci. 1989; 30: 1588–1593
   PubMed Web of Science ®Google Scholar
• Cohen R. A, Gebhardt B. M., Bazan N. G. A platelet-activating factor antagonist reduces corneal allograft inflammation and neovascularization. Curr. Eye Res. 1994; 13: 139–144
   PubMed Web of Science ®Google Scholar
• Asakura T., Matsuda M., Matsuda S., Shichi. Synthesis of 12(R)- and 12(S)-hydroxyeicosatetraenoic acid by porcine ocular tissues. J. Ocular Pharmacol. 1994; 10: 525–535
   PubMedGoogle Scholar
• Conners M. S, Stoltz R. A, Webb S. C, Rosenberg J., Dunn M. W, Abraham N. G, Laniado-Schwartzman M. A closed eye contact lens model of corneal inflammation. Part 1: Increased synthesis of cytochrome p450 arachidonic acid metabolites. Invest. Ophthalmol. Vis. Sci. 1995; 36: 828–840
   PubMed Web of Science ®Google Scholar
• Stoltz R. A, Conners M. S, Dunn M. W., Schwartz-mann M. L. Effect of metabolic inhibitors on arachidonic acid metabolism in the corneal epithelium: evidence for cytochrome P450-mediated reactions. J. Ocul. Pharmacol. 1994; 10: 307–317
   PubMedGoogle Scholar
• Honn K. V, Tang D. G, Gao X., Butovich I. A, Liu B., Timar J., Hagmann W. 12-Lipoxygenases and 12(S)-HETE: role in cancer metastasis. Cancer Metastasis Rev. 1994; 13: 365–396
   PubMed Web of Science ®Google Scholar
• Chen Y. Q, Duniec Z. M, Liu B., Hagmann W., Gao X., Shimoji K., Marnett J., Johnson C. R., Honn K. V. Endogenous 12(S)-HETE production by tumor cells and its role in metastasis. Cancer Res. 1994; 54: 1574–1579
   PubMed Web of Science ®Google Scholar
• Grossi I. M, Fitzgerald L. A, Umbarger L. A, Nelson K. K, Diglio C. A, Taylor J. D., Honn K. V. Bidirectional control of membrane expression and/or activation of the tumor cell IRGpIIb/IIIa receptor and tumor cell adhesion by lipoxygenase products of arachidonic acid and linoleic acid. Cancer Res. 1989; 49: 1029–1037
   PubMed Web of Science ®Google Scholar
• Tang D. G, Timar J., Grossi I. M, Renaud C, Kilmer V. A, Diglio C. A, Taylor J. D., Honn K. V. The lipoxygenase metabolite, 12(S)-HETE, produces a protein kinase C-dependent cytoskeletal rearrangement and retraction of microvascular endothelial cells. Exp. Eye Res. 1993; 207: 361–375
   Google Scholar
• Honn K. V, Tang D. G, Grossi I. M, Duniec Z. M, Timar J., Renaud C, Leithauser M., Blair I., Johnson C. R., Diglio C. R. Tumor cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction. Cancer Res. 1994; 54: 565–574
   PubMed Web of Science ®Google Scholar
• Liu B., Khan W. A, Hannun Y. A, Timar J., Taylor J. D, Lundy S., Butovich I., Honn K. V. 12(S)-Hydroxyeicosatetraenoic acid and 13(S)-hydroxy-octadecadienoic acid regulation of protein kinase C-α in melanoma cells: role of receptor-mediated hydrolysis of inositol phospholipids. Proc. Natl. Acad. Sci. USA 1995; 92: 9323–9327
   PubMed Web of Science ®Google Scholar
• Bhattacherjee P. The role of arachidonate metabolism in ocular inflammation. The Ocular Effects of Prostaglandins and Other Eicosanoids: Progress in Clinical and Biological Research, L. Z. Bito, J. Stjern-schantz. Alan R. Liss, New York 1989; 211–229
   Google Scholar
• Ben-Ezra D. Neovasculogenic ability of prostaglandins, growth factors and synthetic chemoattractants. Am. J. Ophthalmol. 1978, Suppl. 6: 455–461
   PubMedGoogle Scholar
• Goldstein J. B, Puopolo S. M., Praia A. D. The effect of prostaglandin E2 on corneal inflammation in the rat. Exp. Eye Res. 1993; 57: 499–501
   PubMed Web of Science ®Google Scholar
• Becker B., Mills D. W. Corticosteroids and intraocular pressure. Arch. Ophthalmol. 1963; 70: 500–507
   PubMed Web of Science ®Google Scholar